Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 42

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Nov 14, 2025; 31(42): 111708
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111708

Full Size Figure Download Figure

Figure 1 Workflow of the study. YFB: Yiyi Fuzi Baijiang powder; UC: Ulcerative colitis; GO: Gene Ontology; DSS: Dextran sulfate sodium.

Citation: Zhang LK, Gu WC, Chen J. Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment. World J Gastroenterol 2025; 31(42): 111708
URL: https://www.wjgnet.com/1007-9327/full/v31/i42/111708.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i42.111708

Zhang LK, Gu WC, Chen J. Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment. World J Gastroenterol 2025; 31(42): 111708 [PMID: 41278153 DOI: 10.3748/wjg.v31.i42.111708]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.